Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 46

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD

Berton, Danilo C., Reis, Michel, Siqueira, Ana Cristina B., Barroco, Adriano C., Takara, Luciana S., Bravo, Daniela M., Andreoni, Solange, Neder, J. Alberto·2010·Respiratory Medicine
DOI 10.1016/j.rmed.2010.05.017
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.rmed.2010.05.017

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 36

  1. Celli, 2008, Update on the management of COPD, Chest, 133, 1451, 10.1378/chest.07-2061 · DOI
  2. Lötvall, 2001, Pharmacological similarities and differences between β2-agonists, Respir Med, 95S, S7, 10.1053/rmed.2001.1139 · DOI
  3. O’Donnell, 2004, Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD, Eur Respir J, 23, 832, 10.1183/09031936.04.00116004 · DOI · Paper page
  4. Maltais, 2005, Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD, Chest, 128, 1168, 10.1378/chest.128.3.1168 · DOI · Paper page
  5. Neder, 2007, Effects of formoterol on exercise tolerance in severely disabled patients with COPD, Respir Med, 101, 2056, 10.1016/j.rmed.2007.06.006 · DOI · Paper page
  6. Cazzola, 2004, The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD, Pulm Pharmacol Ther, 17, 35, 10.1016/j.pupt.2003.09.001 · DOI
  7. Tennant, 2003, Long-acting beta2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?, Curr Opin Pharmacol, 3, 270, 10.1016/S1471-4892(03)00047-X · DOI
  8. van Noord, 2005, Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD, Eur Respir J, 26, 214, 10.1183/09031936.05.00140404 · DOI
  9. van Noord, 2006, Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD, Chest, 129, 509, 10.1378/chest.129.3.509 · DOI · Paper page
  10. Tashkin, 2008, Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial, Respir Med, 102, 479, 10.1016/j.rmed.2007.12.019 · DOI
  11. Vogelmeier, 2008, Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study, Respir Med, 102, 1511, 10.1016/j.rmed.2008.07.020 · DOI
  12. Tashkin, 2009, Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD, Respir Med, 103, 516, 10.1016/j.rmed.2008.12.014 · DOI
  13. Tashkin, 2009, Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease, Adv Ther, 26, 1024, 10.1007/s12325-009-0080-z · DOI
  14. Hanania, 2009, Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide, Drugs, 69, 1205, 10.2165/00003495-200969090-00005 · DOI
  15. O’Donnell, 2006, Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 3, 180, 10.1513/pats.200508-093DO · DOI · Paper page
  16. Cooper, 2009, Airflow obstruction and exercise, Respir Med, 103, 325, 10.1016/j.rmed.2008.10.026 · DOI
  17. Kaplan, 2004, Measurement of health-related quality of life in the National Emphysema Treatment Trial, Chest, 126, 781, 10.1378/chest.126.3.781 · DOI
  18. Brown, 2008, Exercise testing in severe emphysema: association with quality of life and lung function, COPD, 5, 117, 10.1080/15412550801941265 · DOI
  19. Mahler, 1984, The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes, Chest, 85, 751, 10.1378/chest.85.6.751 · DOI
  20. Neder, 1999, Reference values for lung function tests. I. Static volumes, Braz J Med Biol Res, 32, 703, 10.1590/S0100-879X1999000600006 · DOI
  21. Neder, 1999, Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor), Braz J Med Biol Res, 32, 729, 10.1590/S0100-879X1999000600008 · DOI
  22. Borg, 1982, Psychophysical bases of perceived exertion, Med Sci Sports Exerc, 14, 377, 10.1249/00005768-198205000-00012 · DOI · Paper page
  23. Casaburi, 2005, Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD, Chest, 127, 809, 10.1378/chest.127.3.809 · DOI
  24. Casaburi, 2005, Factors determining constant work rate exercise tolerance in COPD and their role in dictating the minimal clinically important difference in response to interventions, COPD, 2, 131, 10.1081/COPD-200050576 · DOI · Paper page
  25. Puente-Maestu, 2009, Clinical relevance of constant power exercise duration changes in COPD, Eur Respir J, 34, 340, 10.1183/09031936.00078308 · DOI
  26. Mahler, 2006, Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease, Proc Am Thorac Soc, 3, 234, 10.1513/pats.200509-103SF · DOI
  27. O’Donnell, 2006, The clinical importance of dynamic lung hyperinflation in COPD, COPD, 3, 219, 10.1080/15412550600977478 · DOI · Paper page
  28. O’Donnell, 2006, Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD, J Appl Physiol, 101, 1025, 10.1152/japplphysiol.01470.2005 · DOI · Paper page
  29. Mahler, 2005, Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD, Med Sci Sports Exerc, 37, 529, 10.1249/01.MSS.0000158188.90833.38 · DOI
  30. Mahler, 2001, Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness, J Appl Physiol, 90, 2188, 10.1152/jappl.2001.90.6.2188 · DOI
  31. Fierro-Carrion, 2004, Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects, Chest, 125, 77, 10.1378/chest.125.1.77 · DOI
  32. Gross, 1989, Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects, Chest, 96, 984, 10.1378/chest.96.5.984 · DOI
  33. Umeda, 2008, Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD, Respirology, 13, 346, 10.1111/j.1440-1843.2008.01259.x · DOI
  34. Pepin, 2005, Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 172, 1517, 10.1164/rccm.200507-1037OC · DOI
  35. Neder, 2000, Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship, Am J Respir Crit Care Med, 162, 497, 10.1164/ajrccm.162.2.9907122 · DOI
  36. Tashkin, 2009, Formoterol and tiotropium compared with tiotropium alone for treatment of COPD, COPD, 6, 17, 10.1080/15412550902724073 · DOI

Cited by

See all 46

Metadata

Authors
Berton, D. C., Reis, M., Siqueira, A. C. B., Barroco, A. C., Takara, L. S., Bravo, D. M., Andreoni, S., & Neder, J. A.
Venue
Respiratory Medicine
Publisher
Elsevier BV
Published
2010-09
Volume
104
Issue
9
Pages
1288-1296
ISSN
0954-6111
DOI
10.1016/j.rmed.2010.05.017
Cited by
46
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.